Vanessa Suckow

1.5k total citations
11 papers, 743 citations indexed

About

Vanessa Suckow is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Vanessa Suckow has authored 11 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Physiology and 3 papers in Cancer Research. Recurrent topics in Vanessa Suckow's work include RNA modifications and cancer (3 papers), RNA and protein synthesis mechanisms (3 papers) and Pain Mechanisms and Treatments (2 papers). Vanessa Suckow is often cited by papers focused on RNA modifications and cancer (3 papers), RNA and protein synthesis mechanisms (3 papers) and Pain Mechanisms and Treatments (2 papers). Vanessa Suckow collaborates with scholars based in Germany, United States and Austria. Vanessa Suckow's co-authors include Susann Schweiger, Hans‐Hilger Ropers, John Foerster, Thomas Haaf, Elke Raderschall, Karen Stout, Jennifer Winter, Rainer Schneider, Alexander Trockenbacher and Sybille Krauß and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Journal of Neurochemistry.

In The Last Decade

Vanessa Suckow

10 papers receiving 736 citations

Peers

Vanessa Suckow
Nur Yucer United States
Stephan Ryser Switzerland
Audrey O’Neill United States
Margaret Po-shan Luke United States
T. Nagase Japan
Hee-Sae Park South Korea
Matthew T. Knuesel United States
Yu‐Der Wen United States
Vanessa Suckow
Citations per year, relative to Vanessa Suckow Vanessa Suckow (= 1×) peers Benjamin Turgeon

Countries citing papers authored by Vanessa Suckow

Since Specialization
Citations

This map shows the geographic impact of Vanessa Suckow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Suckow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Suckow more than expected).

Fields of papers citing papers by Vanessa Suckow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Suckow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Suckow. The network helps show where Vanessa Suckow may publish in the future.

Co-authorship network of co-authors of Vanessa Suckow

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Suckow. A scholar is included among the top collaborators of Vanessa Suckow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Suckow. Vanessa Suckow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Giuliano, Maria, Elena Putignano, Vanessa Suckow, et al.. (2025). Multi-site investigation of gut microbiota in CDKL5 deficiency disorder mouse models: Targeting dysbiosis to improve neurological outcomes. Cell Reports. 44(4). 115546–115546.
2.
Kotzaeridou, Urania, Sara K. Young, Vanessa Suckow, et al.. (2020). Novel pathogenic EIF2S3 missense variants causing clinically variable MEHMO syndrome with impaired eIF2γ translational function, and literature review. Clinical Genetics. 98(5). 507–514. 10 indexed citations
3.
Hucho, Tim, Vanessa Suckow, Elizabeth K. Joseph, et al.. (2012). Ca++/CaMKII switches nociceptor‐sensitizing stimuli into desensitizing stimuli. Journal of Neurochemistry. 123(4). 589–601. 16 indexed citations
4.
Kuhn, Julia, Olayinka A. Dina, Chandan Goswami, et al.. (2008). GPR30 estrogen receptor agonists induce mechanical hyperalgesia in the rat. European Journal of Neuroscience. 27(7). 1700–1709. 76 indexed citations
5.
Trockenbacher, Alexander, John Foerster, Vanessa Suckow, et al.. (2004). Regulation of the MID1 protein function is fine-tuned by a complex pattern of alternative splicing. Human Genetics. 114(6). 541–552. 22 indexed citations
6.
Winter, Jennifer, Vanessa Suckow, Andreas E. Kulozik, et al.. (2003). Duplication of the MID1 first exon in a patient with Opitz G/BBB syndrome. Human Genetics. 112(3). 249–254. 23 indexed citations
7.
Zeitz, Christina, Harry Scherthan, Silke Feil, et al.. (2003). NYX(Nyctalopin on Chromosome X), the Gene Mutated in Congenital Stationary Night Blindness, Encodes a Cell Surface Protein. Investigative Ophthalmology & Visual Science. 44(10). 4184–4184. 27 indexed citations
8.
Raderschall, Elke, et al.. (2002). Elevated levels of Rad51 recombination protein in tumor cells.. PubMed. 62(1). 219–25. 222 indexed citations
9.
Trockenbacher, Alexander, Vanessa Suckow, John Foerster, et al.. (2001). MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nature Genetics. 29(3). 287–294. 240 indexed citations
10.
Schweiger, Susann, John Foerster, Vanessa Suckow, et al.. (1999). The Opitz syndrome gene product, MID1, associates with microtubules. Proceedings of the National Academy of Sciences. 96(6). 2794–2799. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026